About CareDx
CareDx is a company based in Brisbane (United States) founded in 1998.. CareDx has raised $138.21 million across 19 funding rounds from investors including SVB, Intel and Kleiner Perkins. The company has 650 employees as of December 31, 2024. CareDx has completed 8 acquisitions, including Allenex, BFS Molecular and MedActionPlan. CareDx offers products and services including AlloSure, AlloSeq, and AlloCare. CareDx operates in a competitive market with competitors including Tonix Pharma, Eledon, Kedrion, Aditx Therapeutics and Synklino, among others.
- Headquarter Brisbane, United States
- Employees 650 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Caredx, Inc.
-
Annual Revenue
$333.79 M19.07as on Dec 31, 2024
-
Net Profit
$52.55 M127.62as on Dec 31, 2024
-
EBITDA
$-33.51 M59.17as on Dec 31, 2024
-
Total Equity Funding
$138.21 M (USD)
in 19 rounds
-
Latest Funding Round
$15 M (USD), Debt – Conventional
Mar 01, 2018
-
Investors
SVB
& 15 more
-
Employee Count
650
as on Dec 31, 2024
-
Investments & Acquisitions
Allenex
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CareDx
CareDx is a publicly listed company on the NASDAQ with ticker symbol CDNA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CareDx
CareDx offers a comprehensive portfolio of products and services, including AlloSure, AlloSeq, and AlloCare. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors kidney transplant health through cfDNA analysis
Facilitates organ matching with advanced genetic testing
App for managing transplant patient medications and health
Unlock access to complete
Unlock access to complete
Funding Insights of CareDx
CareDx has successfully raised a total of $138.21M across 19 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $15 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Debt – Conventional — $15.0M
-
First Round
First Round
(01 Apr 2004)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2018 | Amount | Debt – Conventional - CareDx | Valuation |
investors |
|
| Mar, 2017 | Amount | Post-IPO - CareDx | Valuation |
investors |
|
| Jul, 2016 | Amount | Post-IPO - CareDx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CareDx
CareDx has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Intel and Kleiner Perkins. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Growth stage tech & life sciences focused VC firm funding companies in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CareDx
CareDx has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Allenex, BFS Molecular and MedActionPlan. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Organ transplantation management software is provided for healthcare organizations.
|
2020 | ||||
|
Developer of diagnostics for post-transplantation care
|
2017 | ||||
|
Mobile app for medication adherence
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CareDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Caredx Comparisons
Competitors of CareDx
CareDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tonix Pharma, Eledon, Kedrion, Aditx Therapeutics and Synklino, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Next-generation medicines for CNS and immunological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
|
|
| domain | founded_year | HQ Location |
Immune monitoring solutions are provided to the medical community.
|
|
| domain | founded_year | HQ Location |
Drugs for treating chronic viral infections are developed by Synklino.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Caredx
Frequently Asked Questions about CareDx
When was CareDx founded?
CareDx was founded in 1998 and raised its 1st funding round 6 years after it was founded.
Where is CareDx located?
CareDx is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Is CareDx a funded company?
CareDx is a funded company, having raised a total of $138.21M across 19 funding rounds to date. The company's 1st funding round was a Post-IPO of $36.8M, raised on Apr 01, 2004.
How many employees does CareDx have?
As of Dec 31, 2024, the latest employee count at CareDx is 650.
What is the annual revenue of CareDx?
Annual revenue of CareDx is $333.79M as on Dec 31, 2024.
What does CareDx do?
CareDx was founded in 1998 and is headquartered in Brisbane, United States. Precision medicine solutions are offered by the company in the transplant healthcare sector, encompassing products, testing services, and digital tools for pre- and post-transplant care. AlloSure, a non-invasive donor-derived cell-free DNA test, is utilized for detecting kidney injury and rejection in kidney transplant patients. Additional offerings include solutions for heart transplants, laboratory products, and the RemoTraC monitoring service.
Who are the top competitors of CareDx?
CareDx's top competitors include Tonix Pharma, Eledon and Kedrion.
What products or services does CareDx offer?
CareDx offers AlloSure, AlloSeq, and AlloCare.
Is CareDx publicly traded?
Yes, CareDx is publicly traded on NASDAQ under the ticker symbol CDNA.
How many acquisitions has CareDx made?
CareDx has made 8 acquisitions, including Allenex, BFS Molecular, and MedActionPlan.
Who are CareDx's investors?
CareDx has 16 investors. Key investors include SVB, Intel, Kleiner Perkins, Credit Suisse, and TPG.
What is CareDx's ticker symbol?
The ticker symbol of CareDx is CDNA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.